**This call is now closed**
The VALIDATE Network aims to accelerate vaccine research and development for complex intracellular pathogens that cause diseases significant to low and middle-income countries (LMIC), with a focus on Mycobacterium tuberculosis, Leishmania spp, Burkholderia pseudomallei and Mycobacterium leprae. VALIDATE also aims to facilitate Continuing Professional Development (CPD) and career progression amongst its members.
To support these aims, VALIDATE has received funding to support LMIC members (Associates and early-PI Investigators) in publishing original peer-reviewed articles, particularly to make the publication open-access as this has two main benefits:
- Increased visibility and citations of the article and its authors
- Access to the article for all VALIDATE members, disseminating information and widening access to VALIDATE-relevant research
Costs for publication must be incurred before 31 March 2023, when this fund closes.
Please see the our guidance document, below, about this award and how to apply. Please submit your application form and associated documents as one pdf to the VALIDATE Network Manager at VALIDATE@ndm.ox.ac.uk. Do contact the Network Manager at the same address with any queries about the form or the application process.
Applications will be reviewed on a rolling basis, by the VALIDATE Management Team.
List of LMICs (all countries listed on this document count as 'LMIC')